Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.
Cancer Res Commun. 2023 Dec 7;3(12):2483-2496. doi: 10.1158/2767-9764.CRC-23-0298.
Cancer Res Commun. 2023.
PMID: 38009896
Free PMC article.
Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future.
Echavidre W, Fagret D, Faraggi M, Picco V, Montemagno C.
Echavidre W, et al.
Cancers (Basel). 2023 Oct 3;15(19):4839. doi: 10.3390/cancers15194839.
Cancers (Basel). 2023.
PMID: 37835533
Free PMC article.
Review.
Item in Clipboard
Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?
Echavidre W, Picco V, Faraggi M, Montemagno C.
Echavidre W, et al.
Pharmaceutics. 2022 May 13;14(5):1053. doi: 10.3390/pharmaceutics14051053.
Pharmaceutics. 2022.
PMID: 35631639
Free PMC article.
Review.
Item in Clipboard
Cite
Cite